- Home
- U vs LNTH Comparison
U vs LNTH Comparison
Compare U & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | U | LNTH |
|---|---|---|
| Founded | 2004 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.0B | 4.4B |
| IPO Year | 2020 | 2015 |
Fundamental Metrics
Financial Performance| Metric | U | LNTH |
|---|---|---|
| Price | $45.39 | $66.73 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 6 |
| Target Price | $39.84 | ★ $78.00 |
| AVG Volume (30 Days) | ★ 7.0M | 1.1M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.39 |
| Revenue | ★ $1,803,658,000.00 | $1,525,933,000.00 |
| Revenue This Year | $3.29 | $0.01 |
| Revenue Next Year | $13.35 | $0.52 |
| P/E Ratio | ★ N/A | $27.88 |
| Revenue Growth | N/A | ★ 1.95 |
| 52 Week Low | $15.33 | $47.25 |
| 52 Week High | $52.15 | $111.29 |
Technical Indicators
Market Signals| Indicator | U | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 54.32 | 65.42 |
| Support Level | $44.06 | $64.13 |
| Resistance Level | $46.57 | $68.84 |
| Average True Range (ATR) | 2.10 | 1.91 |
| MACD | -0.33 | 0.10 |
| Stochastic Oscillator | 22.12 | 75.07 |
Price Performance
Historical ComparisonAbout U Unity Software Inc.
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run, and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC, and other Americas, and key revenue is derived from the EMEA region. The products are used in the gaming industry, retail, automotive, architecture, engineering, and construction.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.